logo
Populating an Economic Model with Health State Utility Values: Moving toward Better Practice
The Transferability of Valuing Lost Productivity across Jurisdictions. Differences between National Pharmacoeconomic Guidelines
A Cost-Utility Analysis of Microwave Endometrial Ablation versus Thermal Balloon Endometrial Ablation
Evaluating Interventions to Improve Antiretroviral Adherence: How Much of an Effect Is Required for Favorable Value?
Cost–Utility Analysis of Topical Intranasal Steroids for Otitis Media with Effusion Based on Evidence from the GNOME Trial
Assessing the Economic Value of Public Health Programs Based on Risk: The Case of the Cancer Plan in France
Eliciting Distributions to Populate Decision Analytic Models
Cost-Effectiveness of Duloxetine: The Stress Urinary Incontinence Treatment (SUIT) Study
Incorporating Equity–Efficiency Interactions in Cost-Effectiveness Analysis—Three Approaches Applied to Breast Cancer Control
The Cost-Effectiveness of Group Cognitive Behavioral Therapy Compared with Routine Primary Care for Women with Postnatal Depression in the UK
Early-Stage Valuation of Medical Devices: The Role of Developmental Uncertainty
Cost-Effectiveness of Nucleoside Analog Therapy for Hepatitis B in China: A Markov Analysis
Consequences of Screening in Lung Cancer: Development and Dimensionality of a Questionnaire
Constructing a Conceptual Framework of Patient-Reported Outcomes for Metastatic Hormone-Refractory Prostate Cancer
A Portuguese Value Set for the SF-6D
General Population Reference Values for the French Version of the EuroQol EQ-5D Health Utility Instrument
A Valuation of Infusion Therapy to Preserve Islet Function in Type 1 Diabetes
Projecting the Effect of Nesiritide on Dialysis and Hospital Mortality in Cardiac Surgery Patients
Validation and Comparison of EuroQol and Short Form 6D in Chronic Prostatitis Patients
A Review of Quantitative Risk–Benefit Methodologies for Assessing Drug Safety and Efficacy—Report of the ISPOR Risk–Benefit Management Working Group
Empirically Evaluating Decision-Analytic Models
Abolition of Prescription Copayments in Wales: An Observational Study on Dispensing Rates
Network Meta-Analysis: Importance of Appropriate Trial Selection
Response to Comments on “No Study Left Behind: A Network Meta-Analysis in Non–Small-Cell Lung Cancer Demonstrating the Importance of Considering All Relevant Data”
Small Budget Impact Is a Result of Flawed Assumptions and Ignores Questionable Cost-Effectiveness for RSV Prophylaxis